Pharmaceutical Investing TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial 23h
Pharmaceutical Investing Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025 13 October
